Inactive Instrument

Press Releases Provention Bio, Inc.

Equities

PRVB

US74374N1028

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

Provention Bio : Termination of Material Agreement - Form 8-K	23-04-27	PU
PROVENTION BIO, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	23-04-27	AQ
Sanofi Announces $2.9 Billion Acquisition Of BioPharma Diabetes Drug Maker	23-04-10	AQ
PROVENTION BIO, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	23-03-29	AQ
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB	23-03-29	BU
PROVENTION BIO, INC. Financial Statements and Exhibits (form 8-K/A)	23-03-24	AQ
Sanofi to acquire Provention Bio, adding to portfolio TZIELD, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes	23-03-14	AQ
PROVENTION BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Provention Bio, Inc. - PRVB	23-03-13	BU
PROVENTION BIO, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits (form 8-K)	23-03-13	AQ
Provention Bio Cancels Fourth Quarter and Full Year 2022 Earnings Release and Conference Call	23-03-13	PR
Live Stock Market Blog - March 13, 2023 - Business AM	23-03-13	AQ
Provention Bio Announces the Grant of Inducement Awards	23-03-03	PR
Provention Bio to Report Fourth Quarter and Full Year 2022 Financial Results on March 16, 2023	23-02-23	PR
PROVENTION BIO, INC. Change in Directors or Principal Officers (form 8-K/A)	23-02-16	AQ
PROVENTION BIO, INC. : Unregistered Sale of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	23-02-13	AQ
Provention Bio Announces Completion of $35 Million Equity Investment from Sanofi US	23-02-13	PR
Provention Bio to Present at the SVB Securities Global Biopharma Conference	23-02-08	PR
Provention Bio Announces the Grant of Inducement Awards	23-02-03	PR
PROVENTION BIO, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	23-02-02	AQ
AGC Biologics to Commercial Manufacture Provention Bio Diabetes Therapy	23-01-25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Provention Bio, Inc.

Equities

PRVB

US74374N1028

Press Releases

Filters